Women’s health company Allara has raised $30 million in new funding, bringing its total funding to $75 million. Five existing investors, including Index Ventures and GV, increased their investments, while new investors Camino Partners, Foreground Capital, and Family Fund also joined the round.
Allara provides virtual healthcare for women dealing with hormonal, metabolic, and reproductive health conditions. The company combines care from women’s health clinicians and registered dietitians through one platform.
The new funding will help Allara expand access to care, develop AI-powered tools to personalize the patient experience, and advance research into women’s health conditions.
Allara says it has provided care to more than 120,000 women and offers insurance-covered services across much of the United States.
What Allara Is Building?
Allara aims to address gaps in women’s healthcare, where patients can struggle to receive clear answers and coordinated treatment for hormonal and reproductive symptoms.
In a survey of more than 1,600 women joining Allara, 58% said they had already consulted two or more healthcare providers about their symptoms. Among those who had seen another provider, 80% said their symptoms had been dismissed or minimized.
The company brings medical care, nutrition guidance, laboratory testing, and personalized treatment plans together in one place. Its services cover conditions and needs such as polycystic ovary syndrome (PCOS), thyroid disorders, weight management, perimenopause, and reproductive health.
Allara has also expanded its offerings to include GLP-1 medications alongside lifestyle and nutrition support, hormone replacement therapy for perimenopause, prescription skincare and hair-loss treatments, and virtual urgent care for issues such as urinary tract infections and STI testing.
AI and Research Are Key Funding Priorities
Allara plans to invest in AI-enabled tools throughout the patient journey, including patient intake, scheduling, and ongoing treatment management.
The company says these tools are designed to reduce administrative work and help clinicians spend more time with patients. Healthcare providers will remain central to treatment decisions, while patient data will be encrypted and secured.
Another priority is to expand access by partnering with healthcare providers and other organizations. Allara already offers in‑network care through insurers, in most states and plans to grow Allaras existing insurance coverage and clinical infrastructure.
Allara also wants to use its growing patient dataset to push research on conditions that have historically received attention. Those conditions include PCOS, thyroid disorders, endometriosis, postpartum health and perimenopause.
Allara Reports Improvements in Patient Outcomes
According to data shared by the company, 73% of its patients with obesity who had been in care for at least six months lost weight. The company also reported that 48% lost at least 5% of their body weight, while 28% lost 10% or more.
Among members who reported irregular menstrual cycles, 69% said their cycles became more regular. In addition, 89% of surveyed patients said they felt supported in making positive changes to their health, and 78% reported positive changes to their diet.
These figures are based on Allara’s reported patient data and survey findings; they should not be interpreted as independently verified results or a guarantee of outcomes for every patient.
With $75 million in total funding, Allara plans to expand its technology, reach more patients, and contribute to research that could improve understanding of women’s health conditions.
